Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma

Artikel i vetenskaplig tidskrift
Författare Joydeep Bhadury
Lisa M Nilsson
Somsundar Veppil Muralidharan
L. C. Green
Z. L. Li
E. M. Gesner
H. C. Hansen
U. B. Keller
K. G. McLure
Jonas A Nilsson
Publicerad i Proceedings of the National Academy of Sciences of the United States of America
Volym 111
Nummer/häfte 26
Sidor E2721-E2730
ISSN 0027-8424
Publiceringsår 2014
Publicerad vid Institutionen för kliniska vetenskaper, sektionen för kirurgi och kirurgisk gastroforskning, Avdelningen för kirurgi
Sidor E2721-E2730
Språk en
Länkar dx.doi.org/10.1073/pnas.1406722111
Ämnesord mouse models, JQ1, vorinostat, Brd2, Brd4, BROMODOMAIN PROTEIN BRD4, HISTONE DEACETYLASE INHIBITORS, ACUTE, LYMPHOBLASTIC-LEUKEMIA, ACUTE MYELOID-LEUKEMIA, B-CELL LYMPHOMA, C-MYC, P-TEFB, TRANSCRIPTIONAL ELONGATION, SELECTIVE-INHIBITION, DISRUPTION
Ämneskategorier Cancer och onkologi, Medicinsk genetik

Sammanfattning

The bromodomain and extraterminal (BET) domain family of proteins binds to acetylated lysines on histones and regulates gene transcription. Recently, BET inhibitors (BETi) have been developed that show promise as potent anticancer drugs against various solid and hematological malignancies. Here we show that the structurally novel and orally bioavailable BET inhibitor RVX2135 inhibits proliferation and induces apoptosis of lymphoma cells arising in Myc-transgenic mice in vitro and in vivo. We find that BET inhibition exhibits broad transcriptional effects in Myc-transgenic lymphoma cells affecting many transcription factor networks. By examining the genes induced by BETi, which have largely been ignored to date, we discovered that these were similar to those induced by histone deacetylase inhibitors (HDACi). HDACi also induced cell-cycle arrest and cell death of Myc-induced murine lymphoma cells and synergized with BETi. Our data suggest that BETi sensitize Myc-overexpressing lymphoma cells partly by inducing HDAC-silenced genes, and suggest synergistic and therapeutic combinations by targeting the genetic link between BETi and HDACi.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?